Opendata, web and dolomites

DETRIMODE SIGNED

DEgradation TRIggered by MOdular DEsign

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DETRIMODE project word cloud

Explore the words cloud of the DETRIMODE project. It provides you a very rough idea of what is the project "DETRIMODE" about.

grafted    researcher    latter    ligand    oncology    methodology    chance    tpdi    entities    bifunctional    core    tpdis    joined    intermediates    composition    communicated    variety    company    influenced    inducers    public    speed    purinome    combinable    tackles    progressively    discovery    progresses    detrimode    science    shared    close    closer    society    updates    ligands    flexibility    small    molecular    chemical    modular    length    competence    comprised    medchem    engaged    arrays    mutual    drugs    computational    endeavour    technologies    e3    pursued    ligase    cell    synthetic    affinity    ubiquitin    proteasome    therapeutic    disease    degradationtriggered    chemistry    ec    protein    exploited    designed    spacer    ternary    degradation    grow    prospects    linker    proximity    solid    efficiency    synthesis    driving    apt    biology    scope    series    molecule    nms    dept    incrementing    environment    organic    molecules    articulated    ubiquitinating    proteins    stages    multidisciplinary    peers    tripartite    protected    outcomes    recruitment    structural    innovation   

Project "DETRIMODE" data sheet

The following table provides information about the project.

Coordinator
NERVIANO MEDICAL SCIENCES S.R.L 

Organization address
address: VIALE LUIGI PASTEUR 10
city: NERVIANO
postcode: 20014
website: www.nervianoms.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 168˙277 €
 EC max contribution 168˙277 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-05-21   to  2020-07-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NERVIANO MEDICAL SCIENCES S.R.L IT (NERVIANO) coordinator 168˙277.00

Map

 Project objective

The project DETRIMODE (DEgradationTRIggered by MOdular Design) aims at the development of a methodology for the modular synthesis of Targeted Protein Degradation Inducers (TPDI), designed as bifunctional molecules apt to the degradation of target proteins via recruitment of the ubiquitin proteasome system, a process with therapeutic prospects if applied to disease driving proteins. TPDIs are comprised of an E3 ligase ligand and a target protein ligand joined by a spacer (linker), to bring the ubiquitinating system and the target protein in close proximity, so to promote degradation of the latter. The formation of the ternary complex (target protein-TPDI-E3 ligase) is an articulated process influenced by a series of factors, such as ligands affinity, linker length and composition and molecular features of the proteins involved. The project tackles this endeavour in stages of increasing innovation, progressively incrementing the scope, flexibility and efficiency of modular synthetic access to arrays of tripartite molecules via protected, solid grafted intermediates, combinable with a variety of target ligands. New chemical entities TPDIs will be generated targeting selected purinome proteins oncology-related. This project will be pursued within the Chemical Core Technologies Dept. of a fully integrated company (NMS), engaged in the discovery and development of new small molecule based drugs. Organic and solid phase chemistry, computational and structural chemistry, molecular and cell biology, among others, will be exploited to achieve the project’s goal. In such multidisciplinary environment, this new technology will grow at the same speed with the researcher’s medchem competence, increasing the chance of mutual success. DETRIMODE outcomes will be shared with peers, while updates on its progresses as well as general information on how EC-funded research have impact on the general public will be communicated by a number of means, bringing science closer to society

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DETRIMODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DETRIMODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

5G-ACE (2019)

Beyond 5G: 3D Network Modelling for THz-based Ultra-Fast Small Cells

Read More  

MNSWLGM (2019)

An optofluidic platform based on liquid-gradient refractive index microlens for the isolation and quantification of extracellular vesicles

Read More  

LieLowerBounds (2019)

Lower bounds for partial differential operators on compact Lie groups

Read More